IMC Chicago’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-22,470
Closed -$110K 6341
2026
Q1
$76.8K Sell
22,470
-80,460
-78% -$271K ﹤0.01% 5412
2025
Q4
$291K Sell
102,930
-267
-0.3% -$1.38K ﹤0.01% 3819
2025
Q3
$718K Buy
103,197
+16,016
+18% +$113K ﹤0.01% 2942
2025
Q2
$516K Buy
87,181
+40,041
+85% +$230K ﹤0.01% 2845
2025
Q1
$301K Sell
47,140
-74,527
-61% -$719K ﹤0.01% 2927
2024
Q4
$1.45M Buy
121,667
+92,054
+311% +$1.57M ﹤0.01% 2107
2024
Q3
$820K Buy
29,613
+16,112
+119% +$403K ﹤0.01% 2147
2024
Q2
$322K Buy
+13,501
New +$317K ﹤0.01% 2462

Other funds holding ASPN

IMC Chicago's ASPN Position: Q2 2026 in Review

IMC Chicago sold out of Aspen Aerogels (ASPN) in Q2 2026, closing a stake of 22,470 shares — an estimated $110K sold.

IMC Chicago first reported a position in ASPN in Q2 2024 and held it in 8 quarters. The position peaked at $1.45M in Q4 2024. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • IMC Chicago reported no remaining Aspen Aerogels position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 22,470 Aspen Aerogels shares in Q2 2026, an estimated $110K.
  • IMC Chicago first reported a position in Aspen Aerogels in Q2 2024 and held it in 8 quarters.
  • IMC Chicago's Aspen Aerogels position peaked at $1.45M in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.